Evidence map›Paper›PMID 41039190›Full record

ArticleBMC microbiology2025

Comprehensive evaluation of the bactericidal and anti-pathogenic efficacy of chemical disinfectants against antibiotic resistant ESKAPE clinical strains.

Mihaela Magdalena Mitache, Andreea Pîndaru, Ilda Czobor Barbu, Daniela Talapan, Marius Surleac, Ecaterina Sârbu, Luminița Măruțescu, Mariana Carmen Chifiriuc

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mihaela Magdalena MitacheFaculty of Medicine, University Titu Maiorescu, Bucharest, Romania.
Andreea PîndaruDepartment of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.
Ilda Czobor BarbuDepartment of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.
Daniela TalapanNational Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.
Marius SurleacResearch Institute of University of Bucharest, University of Bucharest, Bucharest, Romania.
Ecaterina SârbuResearch Institute of University of Bucharest, University of Bucharest, Bucharest, Romania.
Luminița MăruțescuDepartment of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania. luminita.marutescu@bio.unibuc.ro.
Mariana Carmen ChifiriucDepartment of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.

Funding

CNFIS-FDI CNFIS-FDI-2025-F-0364.The Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) PN-III-P2-2.1-PED-2021-2115 (620 PED)
6 · The paper itself

Abstract

The persistence of nosocomial pathogens in healthcare settings represents a challenge for cleaning and disinfection. Few studies have addressed the efficacy of chemical disinfectants against emergent and multidrug (MDR) resistant ESKAPE bacteria. The aim of this study was to quantify the in-use and off-label efficacy of three commercially available disinfectants: hydrogen-peroxide-, alcohol- and chlorine-based formulations — against twelve genomically characterized ESKAPE pathogens(ST101/258 Klebsiella pneumoniae, ST2 Acinetobacter baumannii, ST131/62 Escherichia coli, ST357 Pseudomonas aeruginosa, ST1 MRSA and ST612/203 vanA-positive Enterococcus faecium) plus four reference strains, and to determine how sub-lethal exposures influence key virulence traits. Disinfectant activity (log₁₀-reduction, LR) was measured by a quantitative suspension test (EN14885) with and without 3% bovine serum albumin. Additional assays simulated real-life use (contaminated nitrile/latex gloves), early biofilm formation (crystal-violet microplate assay) and evaluated the secretion of proteases, phospholipases, lipases and haemolysins. Statistical significance was assessed by one-way ANOVA or unpaired t-tests (P ≤ 0.05). All disinfectants achieved ≥ 5 LR at the manufacturer-specified concentration and contact time; however, efficacy dropped markedly when contact time was halved or concentration reduced. The hydrogen-peroxide-based disinfectant demonstrated minor differences in efficacy. Specifically, the clinical E. faecium 16 VRE strain exhibited higher MBCs compared to the reference strain (3-fold increase) (P < 0.05). A similar behavior was noticed for both clinical Pseudomonas strains that had 4-fold higher MBCs, compared to the P. aeruginosa reference strain (P < 0.05) at a 5-minute contact time. Organic soiling significantly impaired hydrogen peroxide- and chlorine-based disinfectants' activity. On artificially contaminated gloves, the label-strength alcohol-based disinfectant eradicated all strains after 60 s, whereas 30 s exposure or ≥ 25% dilution permitted recovery of up to 10⁵ CFU cm⁻². Sub-inhibitory chlorine or peroxide concentrations reduced early biofilm biomass by 40–70% (P < 0.05) and suppressed extracellular protease/phospholipase activity, while equivalent alcohol exposure had no effect. Manufacturer-recommended concentration and contact time are critical for reliable killing of MDR ESKAPE pathogens. Shortened contact or dilution—common in clinical practice—creates a survival window and may differentially select tolerant species. Chlorine and peroxide formulations additionally attenuate biofilm initiation and soluble virulence factors, suggesting a dual antimicrobial/anti-pathogenic benefit. These findings support strict compliance with label instructions and encourage formulation optimization that couples rapid killing with anti-virulence activity.

Indexed as

Anti-Bacterial AgentsBacteriaDisinfectantsBiofilmsCross InfectionDrug Resistance, BacterialHumansHydrogen PeroxideMicrobial Sensitivity TestsMicrobial ViabilityAnti-Bacterial AgentsDisinfectantsHydrogen PeroxideChemical disinfectantsESKAPE pathogensHealthcare

Identifiers

PMID41039190
PMCPMC12492593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.